Gara Jalqabaatti › Lymphoma B-Cell › Illinois › Chicago
Qorannoo klinikaalii Lymphoma B-Cell Chicago, IL keessatti
Qorannoo 13 Lymphoma B-Cell f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Namoota walitti qabaa jiraSadarkaa 1
- Lurie Children's Hospital, Chicago
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Namoota walitti qabaa jiraSadarkaa 3
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Namoota walitti qabaa jiraSadarkaa 1
- The University of Chicago Medical Center (UCMC), Chicago
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Namoota walitti qabaa jiraSadarkaa 2
- Research Site, Chicago
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Chicago Medical Center, Chicago
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- The David and Etta Jonas Center for Cellular Therapy, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Namoota walitti qabaa jiraSadarkaa 3
- Northwestern, Chicago
- University of Chicago, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
Namoota walitti qabaa jiraSadarkaa 2
- Robert H Lurie Cancer Center, Chicago
Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
- Northwestern University, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Illinois at Chicago Cancer Center, Chicago
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- The University of Chicago Medical Center (UCMC), Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Qorannoo Lymphoma B-Cell magaalota biroo keessatti
- New York City, NYQorannoo 18
- Houston, TXQorannoo 16
- Nashville, TNQorannoo 11
- Philadelphia, PAQorannoo 11
- Rochester, MNQorannoo 10
- Milwaukee, WIQorannoo 9
- Baldwin Park, CAQorannoo 9
- Cleveland, OHQorannoo 9
- Boston, MAQorannoo 8
- Salt Lake City, UTQorannoo 8
- Washington, DCQorannoo 7
- Pittsburgh, PAQorannoo 7
Qorannoo biroo Chicago keessatti
- Kansara Qara'a Non-Small CellQorannoo 61
- Saree OljooQorannoo 59
- Saree (Gosoota Hunda)Qorannoo 51
- Kansara MetastatikiiQorannoo 45
- Kansarii ProstateQorannoo 45
- Dhibee QaraQorannoo 41
- ObesityQorannoo 41
- Kansarii OvariiQorannoo 36
- Kansarii ColorectalQorannoo 34
- StrokeQorannoo 34
- Cufama OnneeQorannoo 31
- Baayyee UlfaataaQorannoo 29
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.